X - Systemic/Distant conditions, syndromes and reactions
Subclinical ANA positivity
Last update 17/06/2026
(ANA : Antinuclear antibodies). Subclinical organ damage or dysfuction should be investigated. See also under Xd and Xe
X - Systemic/Distant conditions, syndromes and reactions
Last update 17/06/2026
(ANA : Antinuclear antibodies). Subclinical organ damage or dysfuction should be investigated. See also under Xd and Xe
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic